ELISA Kit for Creatine Kinase MB Isoenzyme (CKMB)
SEA479MU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Creatine Kinase MB Isoenzyme (CKMB)
- Delivery Days Customer12
- Assay Detection Range0.78-50ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Creatine Kinase MB Isoenzyme (CKMB) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 0.32ng/mL
- Assay Test PrincipleThe microplate provided in this kit has been pre-coated with an antibody specific to CKMM. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to CKBB. Next, Avidin conjugated to ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Gao S, Wang R, Dong S, et al. Inactivation of TOPK Caused by Hyperglycemia Blocks Diabetic Heart Sensitivity to Sevoflurane Postconditioning by Impairing the PTEN/PI3K/Akt Signaling. Oxid Med Cell Longev. 2021,2021:6657529. doi: 10.1155/2021/6657529Read this paper
- Kanno SI, Hara A. The mRNA expression of Il6 and Pdcd1 are predictive and protective factors for doxorubicin‑induced cardiotoxicity. Mol Med Rep. 2021,23(2):pii: 113. doi: 10.3892/mmr.2020.11752.Read this paper
- Qiu Y, Wu Y, Meng M, et al. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice. J Surg Res. 2018,225:29-39. doi: 10.1016/j.jss.2017.12.030Read this paper
- Liu G, Wu K, Zhang L, et al. Metformin attenuated endotoxin-induced acute myocarditis via activating AMPK. Int Immunopharmacol. 2017,47:166-172. doi: 10.1016/j.intimp.2017.04.002Read this paper
- Gao S, Yang Z, Shi R, et al. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling. Eur J Pharmacol. 2016,779:111-21. doi: 10.1016/j.ejphar.2016.03.018Read this paper
